ASPAR

This brand name is authorized in Poland

Active ingredients

The drug ASPAR contains a combination of these active pharmaceutical ingredients (APIs):

1 Magnesium hydrogen aspartate
UNII 082H981FMA - MAGNESIUM ASPARTATE ANHYDROUS

Magnesium is a cofactor in >300 enzymatic reactions. It acts as an essential co-factor for all ATP-binding enzymes. Magnesium plays an important role in cellular electrolyte homeostasis and in the neuromuscular membrane stabilization.

Read about Magnesium aspartate
2 Potassium hydrogen aspartate
UNII E9VW2509NH - POTASSIUM ASPARTATE ANHYDROUS
Read about Aspartic acid

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A12CX Other mineral products A Alimentary tract and metabolism → A12 Mineral supplements → A12C Other mineral supplements
Discover more medicines within A12CX

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: PL Rejestru Produktรณw Leczniczych Identifier(s): 100246459

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.